相关实验视频
Updated: Jun 21, 2025

04:49
Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
433
在帕金森病中对小分子α-synuclein的免疫反应 周围血液单核细胞 帕金森病
Ana Florencia Vega-Benedetti1, Clara Porcedda1, Tommaso Ercoli2
1Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Journal of neurology
|July 10, 2024
概括
帕金森病患者表现出与症状严重程度相关的免疫细胞简介变化. 暴露于α-synuclein的健康细胞模仿了这种失调,这表明免疫系统参与了帕金森病的异质性.
科学领域:
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
背景情况:
- 帕金森病 (PD) 呈现出各种运动和非运动症状,可能是由于不同的α-synuclein (α-syn) 病理起源 (大脑优先与身体优先).
- 免疫系统失调与中部和外围PD病理有关,α-syn在神经退行和炎症的关联中.
研究的目的:
- 在帕金森病患者中表征外周血液单核细胞 (PBMC) 的炎症特征和免疫表型.
- 为了研究免疫参数和PD的临床运动/非运动症状之间的关系.
- 探索α-synuclein (α-syn) 刺激对PD患者和健康对照的PBMCs的影响.
主要方法:
- 从21名PD患者和18名健康对照人群中分离出周围血液单核细胞 (PBMC).
- 用α-syn单体或寡合体对PBMC进行体外刺激.
- 使用Multiplex ELISA测量细胞因子/化学因子释放,并通过FACS流细胞计进行免疫表型分析.
- 免疫参数和临床尺度之间的相关性分析 (例如,运动,非运动,嗅觉,便秘).
主要成果:
- 患有PD的患者表现出失调的PBMC细胞因子概况,独立于α-syn刺激,与运动和非运动症状严重程度相关,特别是嗅觉障碍.
- 健康对照PBMC暴露于α-syn增加了细胞因子/化学因子的释放,达到PD患者的水平.
- 在PD患者和对照人群中观察到明显的PBMC免疫表型,与嗅觉障碍 (单细胞子集) 和便秘 (NK细胞) 相关的特定免疫细胞概况.
结论:
- 在帕金森病患者中,异常的外周免疫特征可能反映出不同的临床亚型.
- 这些发现支持基于免疫系统参与的PD被分类为外周第一与大脑第一的表型.
- 免疫细胞简介为特定的PD症状和疾病亚型提供了潜在的生物标志物.
更多相关视频
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.7K
08:33Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
8.2K
相关概念视频
Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
Parkinson's Disease: Overview
522
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
522
Parkinson's Disease: Treatment
251
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
251